Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 11428

Long Beach, CA 90813


Study Summary:

A phase III, randomized, double-blind and placebo-controlled study of once daily bi 201335 120 mg for 24 weeks and bi 201335 240 mg for 12 weeks in combination with pegylated interferon-a and ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C infection.


Qualified Participants Must:

• Be 18-70 years of age
• Have chronic Hepatitis C
• Have never been treated with HCV medications
• Be willing to attend up to 13 clinic visits over 72 weeks


Qualified Participants May Receive:

Study related medical exams and follow-ups, laboratory tests, and study medications.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.